Hemolysis area: A new parameter of erythrocyte osmotic fragility for screening of thalassemia trait

T Tatu, D Sweatman - Journal of Laboratory Physicians, 2018 - thieme-connect.com
T Tatu, D Sweatman
Journal of Laboratory Physicians, 2018thieme-connect.com
BACKGROUND: One-tube osmotic fragility test (OFT) is widely used for screening
thalassemia traits. Interobserver variation may occur with 0.36% NaCl-based OFT due to the
naked eye result reading style. PURPOSE: The purpose of this study was to establish and
evaluate the novel numerical OFT-based parameter, so-called hemolysis area (HA), in
screening thalassemia traits. MATERIALS AND METHODS: The portable spectrophotometer
was invented capable of calculating the HA values. The HA values were then compared …
BACKGROUND: One-tube osmotic fragility test (OFT) is widely used for screening thalassemia traits. Interobserver variation may occur with 0.36% NaCl-based OFT due to the naked eye result reading style.
PURPOSE: The purpose of this study was to establish and evaluate the novel numerical OFT-based parameter, so-called hemolysis area (HA), in screening thalassemia traits.
MATERIALS AND METHODS: The portable spectrophotometer was invented capable of calculating the HA values. The HA values were then compared among 69, 156, and 19 blood samples having positive, negative, and suspicious 0.36% NaCl-based OFT results, respectively; 109 and 135 blood samples having mean corpuscular volume (MCV) ≤80 fL and >80 fL, respectively; and 138 and 106 blood samples having mean corpuscular hemoglobin (MCH) ≤27 pg and >27 pg, respectively. In addition, the HA values were compared in 166 blood samples having different globin gene genotypes. Finally, the HA cutoff value was determined by receiver operation curve (ROC) analysis.
RESULTS: The HA values in samples having positive, suspicious, and negative 0.36% NaCl-based OFT were 33.3 ± 14.4, 42.9 ± 10.5, and 65.3 ± 13.4, respectively; in sample having MCV ≤80 fL and >80 fL were 43.1 ± 19.6 and 63.8 ± 14.5, respectively; and in samples having MCH ≤27 pg and >27 pg were 46.7 ± 20.1 and 64.8 ± 14.2, respectively. The HA values in normal, hemoglobin E, SEA-a thalassemia 1, and β-thalassemia traits were 67.1 ± 12.6, 36.4 ± 13.9, 20.2 ± 4.8, and 18.6 ± 1.1, respectively. All were significantly different. ROC analysis established 52.4 as the HA cutoff that had comparable effectiveness to the conventional screening tests.
CONCLUSION: The new HA value was effective and could be an alternative choice for screening thalassemia traits.
Thieme Connect